Gauci et al. also suggested that the presence of anti-GAD antibody is related to the shortness of the period from the initial ICI treatment to the onset of ICI-associated type 1 diabetes [10], but that possibility remains to be elucidated. The gene discussed is GAD1; the disease is type 1 diabetes mellitus.